Researchers at UT Southwestern Medical Center have identified a protein that causes human cell membranes to break open in a ...
Study Finds on MSN
Cannabis Compounds Stop Ovarian Cancer Cells From Surviving in Lab Tests
CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...
EPFL scientists have identified a molecular pathway that protects cells from lipid oxidation and ferroptosis, a regulated ...
AZoLifeSciences on MSN
SIGLEC12 Identified as Key Driver Of Necroptosis in Humans
Researchers at UT Southwestern Medical Center have identified a protein that causes human cell membranes to break open in a ...
AZoLifeSciences on MSN
Researchers elucidate microtubule-mediated cell signal transduction
The most diverse functions of a cell in the human body – from cell division and differentiation to motility and programmed cell death – are controlled by signaling proteins within the cell. This ...
Microtubules perform an active role in communication within the cell by transmitting received signals to the cell's ...
News-Medical.Net on MSN
Scientists map how cinnamon’s bioactives interact with cancer signaling
This review synthesizes preclinical evidence showing that cinnamon-derived compounds can modulate inflammation, oxidative ...
News-Medical.Net on MSN
Triaptosis could be a promising strategy in the fight against cancer
Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens while limiting gains in human life expectancy.
HealthDay on MSN
Timing of Immune Checkpoint Inhibitor Administration Affects Small Cell Lung Cancer Survival
Patients with extensive-stage SCLC who received immunochemotherapy before 15:00 hrs exhibited significantly longer PFS, overall survival.
Scientists at Northwell Health's Feinstein Institutes for Medical Research are making strides in controlling the severe inflammation that is the hallmark of sepsis. This severe condition occurs when ...
PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939, AS A PROMISING DRUG CANDIDATE FOR TREATING REFRACTORY ACUTE ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果